Enzyme Design

Researchers create synthetic enzymes in the lab, encoded by artificial genetic material.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, KA2RINAOver the past several years, researchers have begun making synthetic genetic polymers they called XNAs, which incorporate alternative molecules in place the ribose or deoxyribose portions of RNA and DNA, and a couple of years ago, Philipp Holliger of the U.K.’s MRC Laboratory of Molecular Biology and his team showed that these nucleic acids can replicate and evolve just like the real thing. Now, the group has used XNAs to encode and produce artificial enzymes that, once again, function just as well as natural molecules, capable of constructing and breaking down other compounds, according to research published this week (December 1) in Nature.

“Our work suggests that, in principle, there are a number of possible alternatives to nature’s molecules that will support the catalytic processes required for life,” Holliger told BBC News. “Life’s ‘choice’ of RNA and DNA may just be an accident of prehistoric chemistry.”

The research points to the possibility of life forms based on molecules other than DNA, structural biologist Paul Freemont of Imperial College London, told the BBC. “It provokes people to think that what we see on our planet is just one chemical possibility. It’s the pure challenge of the chemistry of life.”

Additionally, Holliger noted, the synthetic nucleic acid/enzyme system could provide a new way to make human therapeutics. Because the XNAs do not exist in nature, they are immune to the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies